A 28-year-old woman with a known history of phenylketonuria (PKU) managed on a phenylalanine-restricted diet presents to the antenatal clinic at 8 weeks gestation. Her current plasma phenylalanine level is 18 mg/dL (target <6 mg/dL for pregnancy). The obstetrician is concerned about adverse fetal outcomes. Which of the following is the primary mechanism by which elevated maternal phenylalanine causes fetal damage in the absence of fetal PKU?

Explanation

## Maternal PKU and Fetal Damage: Mechanism ### Clinical Context: Maternal PKU Syndrome **Key Point:** Even if the fetus is heterozygous (carrier) or homozygous normal for phenylalanine hydroxylase, it can suffer severe damage from maternal hyperphenylalaninemia. This is called **maternal PKU syndrome** or **fetal PKU syndrome**. ### Pathophysiology The primary mechanism of fetal damage is **competitive inhibition of neutral amino acid transporters** in the placenta: ```mermaid flowchart TD A["Maternal hyperphenylalaninemia<br/>Phe > 10 mg/dL"]:::urgent --> B["Excessive placental uptake<br/>of phenylalanine"]:::outcome B --> C{"Competition for neutral<br/>amino acid transporters<br/>LAT1, LAT2, y+LAT"}:::decision C -->|"Phenylalanine wins<br/>competition"|D["Reduced placental transfer of:<br/>• Tyrosine<br/>• Tryptophan<br/>• Leucine<br/>• Other large neutral AAs"]:::urgent D --> E["Fetal tyrosine deficiency"]:::urgent E --> F["↓ Catecholamine synthesis<br/>↓ Melanin synthesis<br/>↓ Protein synthesis"]:::outcome F --> G["Microcephaly<br/>Intellectual disability<br/>Congenital heart defects<br/>Growth restriction"]:::urgent ``` ### Why Tyrosine Deficiency Matters in Fetal Development **High-Yield:** Tyrosine is **conditionally essential** during fetal development. Although normally synthesized from phenylalanine, the fetus cannot produce enough tyrosine when: 1. Maternal phenylalanine is elevated (competitive inhibition of placental transport) 2. The fetal liver has immature phenylalanine hydroxylase activity Tyrosine is critical for: - **Catecholamine synthesis** (noradrenaline, adrenaline, dopamine) — essential for fetal cardiac development and CNS maturation - **Melanin synthesis** — explains hypopigmentation in maternal PKU offspring - **Thyroid hormone synthesis** (T₃, T₄) — crucial for CNS myelination and growth - **Protein synthesis** — needed for normal fetal growth ### Fetal Outcomes in Uncontrolled Maternal PKU | Outcome | Incidence | Mechanism | |---------|-----------|----------| | Intellectual disability | 90% | Tyrosine deficiency + direct phenylalanine toxicity | | Microcephaly | 75% | Impaired CNS growth and myelination | | Congenital heart defects | 15–30% | Impaired catecholamine-dependent cardiac development | | Growth restriction | 40% | Reduced placental amino acid transfer | | Hypopigmentation | 70% | Reduced melanin synthesis | | Neonatal hypocalcaemia | Common | Impaired parathyroid development | **Clinical Pearl:** The fetus is **not protected** by the maternal blood–brain barrier. Phenylalanine crosses the placenta freely via amino acid transporters, and fetal plasma phenylalanine is typically **higher** than maternal levels (2–3× higher) due to placental accumulation and fetal inability to metabolize it. ### Management: Strict Maternal Dietary Control **Key Point:** Maternal PKU women should maintain plasma phenylalanine **<6 mg/dL** (ideally <4 mg/dL) **before conception and throughout pregnancy**. 1. **Preconception counselling** — optimize phenylalanine levels before pregnancy 2. **Phenylalanine-restricted diet** — low-protein foods, special medical foods 3. **Supplementation** — tyrosine (conditionally essential), vitamins, minerals 4. **Frequent monitoring** — plasma phenylalanine levels every 1–2 weeks during pregnancy 5. **Multidisciplinary care** — metabolic specialist, obstetrician, dietitian **Warning:** Even if the fetus inherits normal or heterozygous genotype for phenylalanine hydroxylase, it cannot escape maternal hyperphenylalaninemia. Genetic testing of the fetus does NOT predict fetal outcome; only maternal phenylalanine control matters.